Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chuanqiang Wu
Observed name:
Wu, Chuanqiang
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Second Affiliated Hospital of Zhejiang University,
Tianjin Medical University,
Zhejiang University
ORCID:
0000-0002-0895-0532
Observed ORCID:
0000-0002-0895-0532
OpenAlex ID:
A5089771234
YAP drives fate conversion and chemoresistance of small cell lung cancer
2021
·
Qingzhe Wu
, Jingxin Guo
, et al.
·
Science Advances
·
135
TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions
2018
·
Yu Wang
, Chuanqiang Wu
, et al.
·
Cancer Letters
·
99
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner
2018
·
Shanshan Sun
, Yansheng Wu
, et al.
·
Clinical Cancer Research
·
98
Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells
2022
·
Lingjun Dong
, Fuxiang Liang
, et al.
·
Cells
·
51
PDF
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
2018
·
Yu Wang
, Wenyu Guo
, et al.
·
International Journal of Oncology
·
47
PDF
Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis
2019
·
Minghui Zhao
, Xiaomeng Hu
, et al.
·
International Journal of Oncology
·
33
PDF
Paravertebral vs Epidural Anesthesia for Video-assisted Thoracoscopic Surgery: A Randomized Trial
2023
·
Zixiang Wu
, Qi Wang
, et al.
·
The Annals of Thoracic Surgery
·
28
PDF
A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
2019
·
Zhaoqing Li
, Tingting Zhu
, et al.
·
PubMed
·
21
m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma
2023
·
Yafei Liu
, Bin Jiang
, et al.
·
Frontiers in Oncology
·
17
Long Non-Coding RNA OIP5-AS1 Inhibits the Proliferation and Migration of Esophageal Squamous Carcinoma Cells by Targeting FOXD1/miR-30a-5p Axis and the Effect of Micro- and Nano-Particles on Targeting Transfection System
2021
·
Qihang Yan
, Li Liu
, et al.
·
Journal of Biomedical Nanotechnology
·
14
Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer
2024
·
Yuning Liu
, Qingzhe Wu
, et al.
·
Molecular Cancer Research
·
11
PDF
Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial
2024
·
Zixiang Wu
, Chuanqiang Wu
, et al.
·
EClinicalMedicine
·
10
PDF
Aquaporin-1 inhibition exacerbates ischemia-reperfusion-induced lung injury in mouse
2022
·
Qi Wang
, Yangfan Li
, et al.
·
The American Journal of the Medical Sciences
·
9
Hypoxia inhibits the iMo/cDC2/CD8+ TRMs immune axis in the tumor microenvironment of human esophageal cancer
2024
·
Chuanqiang Wu
, Huan Yu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma.
2017
·
Chao Jing
, Xin Qu
, et al.
·
PubMed
·
7
Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database
2021
·
Congcong Chen
, Zixiang Wu
, et al.
·
BMC Cancer
·
5
PDF
Deep Learning Identifies HAT1 as a Morphological Regulator in Esophageal Squamous Carcinoma Cells through Controlling Cell Senescence
2023
·
Yuefeng Wu
, Bin Jiang
, et al.
·
Advanced Intelligent Systems
·
3
PDF
Neoadjuvant serplulimab combined with chemotherapy for resectable oesophageal squamous cell carcinoma: a single-arm, phase 2 trial
2025
·
Zixiang Wu
, Chuanqiang Wu
, et al.
·
Nature Communications
·
2
1319 First-in-human study of a personalized neoantigen peptide vaccine (iNeo-Vac-P01) for postoperative esophageal cancer in a Chinese cohort
2025
·
Ming Wu
, Hong Shen
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
LOX and Its Methylation Impact Prognosis of Diseases and Correlate with TAM Infiltration in ESCA
2022
·
Chuanqiang Wu
, Bin Jiang
, et al.
·
Journal of Oncology
·
2
PDF
[Retracted] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
2025
·
Yu Wang
, Wenyu Guo
, et al.
·
International Journal of Oncology
·
1
PDF
Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis
2024
·
Jinghao Huang
, Yifan Yu
, et al.
·
BMC Cancer
·
1
PDF
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion
2023
·
Yu Wang
, Wenyu Guo
, et al.
·
International Journal of Oncology
·
1
PDF
Personalized neoantigen vaccine as adjuvant therapy in high-risk postoperative esophageal carcinoma.
2026
·
Ming Wu
, Hong Shen
, et al.
·
Journal of Clinical Oncology
Abstract 4366: Individualized neoantigen vaccine as adjuvant therapy in high-risk esophageal carcinoma: A study with the largest reported cohort and longest follow-up to date
2026
·
Ming Wu
, Hong Shen
, et al.
·
Cancer Research
Show more works
View as search
Works count:
41
Citation count:
605
H-index:
11
I10-index:
12
Year
Topic
Type